Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications.

Sangmin Lee Cynthia H-T SeowKamala AdhikariAmy Metcalfe

Published in: Alimentary pharmacology & therapeutics (2019)

Almost a quarter of women with IBD who were previously adherent to medical therapy were not adherent during pregnancy. Adherence pattern differed by drug class.

Keyphrases

pregnant women
rheumatoid arthritis
healthcare
ulcerative colitis
emergency department
type diabetes
glycemic control
adverse drug
bone marrow
drug induced
adipose tissue
cell therapy